Cerluten is a neural-tissue bioregulator peptide that supports the central nervous system through epigenetic modulation. Its ultra-short amino acid chains promote balanced neurotransmitter synthesis, neuronal membrane repair, and synaptic efficiency.
Cerluten is a precision-engineered bioregulator peptide that selectively targets central nervous system through epigenetic signalling pathways. Developed from decades of Khavinson peptide research, each capsule contains ultra-short amino acid sequences (2-4 residues) that penetrate cell membranes to interact directly with tissue-specific DNA. By restoring natural gene expression patterns within central nervous system cells, Cerluten helps normalise neuronal signaling and cognitive neurotransmitter balance—functions that progressively decline with age, stress, and environmental exposure. The peptide does not introduce foreign substances; instead, it reactivates the body's own molecular programmes for neurological tissue maintenance, making it a fundamentally different approach from conventional supplementation.